Alterations in Serum Ischemia-Modified Albumin and Nitric Oxide in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Endocrinology Research and Practice · 06.07.2026 · 30 (3)
DOI: 10.5152/erp.2026.25894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology Research and Practice, online erschienen am 06.07.2026. Verfasst von Tushar Sethi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
Oxidative stress serves a pivotal role in the onset and advancement of type 2 diabetes mellitus (T2DM). Ischemia-modified albumin (IMA) and nitric oxide (NO) are biochemical markers reflecting oxidative imbalance. Their clinical relevance in newly diagnosed T2DM remains incompletely explored.
Methods
This cross-sectional study involved 50 newly diagnosed T2DM patients aged 40-65 years and 50 healthy controls matched for age and sex. Serum IMA and NO levels were measured using colorimetric assays. Data were analyzed using independent t-tests after checking normality with the Kolmogorov–Smirnov test, along with Pearson correlation and multiple linear regression analyses.
Results
Patients with T2DM had significantly higher serum IMA (0.598 ± 0.13 absorbance unit (AU) vs. 0.279 ± 0.07 AU; P < .05) and NO (57.41 ± 9.41 μmol/L vs. 36.03 ± 4.15 μmol/L; P < .05) compared to controls. No significant correlations were seen between IMA, NO, or glucose parameters. Multiple linear regression analysis showed that higher levels of IMA and NO were not associated with T2DM status.
Conclusion
Increased serum IMA and NO levels in newly diagnosed T2DM reflect early oxidative stress and endothelial alterations. The absence of correlation between glucose parameters and among themselves indicates distinct but complementary pathophysiological mechanisms. These findings are exploratory, and larger longitudinal studies are required to determine their clinical or diagnostic utility. Cite this article as: Sethi T, Dahiya K, Fotedar S. Alterations in serum ischemia-modified albumin and nitric oxide in patients with newly diagnosed type 2 diabetes mellitus. Endocrinol Res Pract. 2026;30(3):171-176.
Zitieren
APA
Sethi, T., Dahiya, K., & Fotedar, S. (2026). Alterations in Serum Ischemia-Modified Albumin and Nitric Oxide in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Endocrinology Research and Practice, 30(3). https://doi.org/10.5152/erp.2026.25894
Vancouver
Sethi T, Dahiya K, Fotedar S. Alterations in Serum Ischemia-Modified Albumin and Nitric Oxide in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Endocrinology Research and Practice. 2026;30(3). doi:10.5152/erp.2026.25894
BibTeX
@article{Sethi2026,
author = {Sethi, Tushar and Dahiya, Kiran and Fotedar, Sanjay},
title = {Alterations in Serum Ischemia-Modified Albumin and Nitric Oxide in Patients with Newly Diagnosed Type 2 Diabetes Mellitus},
journal = {Endocrinology Research and Practice},
year = {2026},
volume = {30},
number = {3},
doi = {10.5152/erp.2026.25894}
}
EUVIMED